Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Immunic, Inc. - Common Stock (NQ:IMUX)

8.180 -0.010 (-0.12%)
Delayed Quote Updated: 11:03 AM EDT, Oct 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about Immunic, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Immunic CEO hails "great day" after completing IMU-838 phase 2 trial enrolment
--News Direct-- 
Via News Direct
Immunic CEO hails "great day" after completing IMU-838 phase 2 trial enrolment
Immunic Inc (NASDAQ:IMUX) President and CEO Dr Daniel Vitt speaks to Thomas Warner from Proactive after the biotechnology company announced the completion of the enrolment of its phase 2 CALLIPER trial... 
Via TheNewswire.com
Immunic CEO says Q2 results "couldn't be better"
--News Direct-- 
Via News Direct
Immunic CEO says Q2 results "couldn't be better"
Immunic Inc (NASDAQ:IMUX) president and CEO Dr Daniel Vitt speaks to Thomas Warner from Proactive following the release of the Munich-based biotechnology company's second-quarter financial results and... 
Via TheNewswire.com
Immunic Inc eyeing "big step" for multiple sclerosis patients
Immunic Inc (NASDAQ:IMUX) president and CEO Dr Daniel Vitt joined Thomas Warner from Proactive ahead of World Brain Day to provide an update on the biotechnology company's novel multiple sclerosis (MS)... 
Via TheNewswire.com
Immunic Inc eyeing "big step" for multiple sclerosis patients
--News Direct-- 
Via News Direct
News headline image
Immunic Inc set to bring relief with encouraging results
Immunic Inc set to bring relief with encouraging results 
Via News Direct
Immunic Inc set to bring relief with encouraging results
Dr Daniel Vitt, CEO of Immunic Inc (NASDAQ:IMUX), discusses the company's encouraging first-quarter performance with Proactive. 
Via TheNewswire.com
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Recap: Immunic Q1 Earnings ↗
 
Via Benzinga
News headline image
Immunic IMU-856 trial data "clearly goes beyond" initial expectations
Immunic IMU-856 trial data "clearly goes beyond" initial expectations 
Via News Direct
Immunic IMU-856 trial data "clearly goes beyond" initial expectations
Immunic Inc (NASDAQ:IMUX) CEO Dr. Daniel Vitt speaks to Thomas Warner from Proactive after releasing new clinical trial data for the biotechnology company's IMU-856 molecule, which is aimed at... 
Via TheNewswire.com
Immunic gets a "positive surprise" from lead asset trial
Immunic Inc (NASDAQ:IMUX) CEO Dr. Daniel Vitt speaks to Proactive following the release of data from the maintenance phase of its phase 2b CALDOSE-1 trial of lead asset vidofludimus calcium (IMU-838)... 
Via TheNewswire.com
News headline image
Why Is Immunic (IMUX) Stock Up 23% Today? ↗
Immunic (IMUX) stock is getting a boost on Wednesday after the company released results from its Phase 2 CALDOSE-1 Trial. 
Via InvestorPlace
News headline image
Preview: Immunic's Earnings ↗
 
Via Benzinga
News headline image
Immunic Touts Positive Vidofludimus Calcium Data In Multiple Sclerosis Candidate ↗
 
Via Benzinga
News headline image
Immunic gets a "positive surprise" from lead asset trial
Immunic gets a "positive surprise" from lead asset trial 
Via News Direct
News headline image
Why Kura Sushi Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 104% to $5.55 after the company announced it has been selected by the U.S. Department of Defense for a position on the multiple award Indefinite... 
Via Benzinga
News headline image
After Positive Data In Ulcerative Colitis Study, Immunic Prioritizes Vidofludimus Calcium Program With One More Candidate ↗
 
Via Benzinga
News headline image
Why Is Nuvve (NVVE) Stock Down 14% Today? ↗
Nuvve (NVVE) stock is down on Wednesday after the vehicle-to-grid technology company's shares underwent a rally yesterday. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Is Secoo (SECO) Stock Down 16% Today? ↗
Secoo (SECO) stock is retreating on Wednesday after the Chinese products and services company saw a massive rally on Tuesday. 
Via InvestorPlace
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
We're starting off Wednesday with a breakdown of the biggest pre-market stock movers traders need to know about this morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
BARK And 3 Other Stocks Under $2 Insiders Are Aggressively Buying ↗
The Dow Jones closed higher by more than 150 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
We're beginning the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday morning! 
Via InvestorPlace
News headline image
Recap: Immunic Q3 Earnings ↗
Immunic (NASDAQ:IMUX) reported its Q3 earnings results on Thursday, November 3, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings Immunic missed estimated earnings... 
Via Benzinga
News headline image
Immunic's Earnings Outlook ↗
Immunic (NASDAQ:IMUX) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Immunic will report... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.